Chris Nasveschuk

Senior Vice-President of Chemical Sciences C4 Therapeutics Inc

Seminars

Wednesday 29th October 2025
Advancing CNS Penetrant Degraders Through Emerging Design Principles to Cross the BBB
1:30 pm
Screenshot 2025-08-26 122916